Sol-Gel Technologies (SLGL) VP discloses shares and option grants

Rhea-AI Filing Summary

Sol-Gel Technologies Ltd. executive Ofer Toledano, VP Research & Development, filed an initial insider ownership report. He directly holds 1,461 Ordinary Shares and a series of stock options over Ordinary Shares with exercise prices ranging from 8.9600 to 100.0000, expiring between 2026 and 2035. Several options are already fully vested, while others vest in quarterly installments over three years, contingent on continued service.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Toledano Ofer

(Last) (First) (Middle)

C/O SOL-GEL TECHNOLOGIES LTD.

7 GOLDA MEIR STREET

(Street)

NESS ZIONA 7403650

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Sol-Gel Technologies Ltd. [ SLGL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Research & Dev.

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	1,461	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	08/01/2026	Ordinary Shares	712	$15.89	D
Stock Option (right to buy)	(2)	07/13/2027	Ordinary Shares	4,460	$55.66	D
Stock Option (right to buy)	(3)	03/29/2032	Ordinary Shares	7,615	$100	D
Stock Option (right to buy)	(4)	03/09/2033	Ordinary Shares	8,487	$56	D
Stock Option (right to buy)	(5)	02/18/2035	Ordinary Shares	1,000	$8.96	D

Explanation of Responses:

1. The option is fully vested.

2. The option is fully vested.

3. The option vested as to 25% of the Ordinary Shares, NIS 1.00 par value per share ("Ordinary Shares") on March 29, 2023 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.

4. The option vested as to 25% of the Ordinary Shares on March 9, 2024 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.

5. The option vested as to 25% of the Ordinary Shares on February 18, 2026 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.

Remarks:

Exhibit 24 - Power of Attorney

	/s/Eyal Ben-Or, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Sol-Gel Technologies (SLGL) Form 3 filing show for Ofer Toledano?

The Form 3 shows that VP Research & Development Ofer Toledano holds 1,461 Ordinary Shares and multiple stock option grants on Sol-Gel shares, with various exercise prices and expirations, as his initial reported ownership position.

How many Sol-Gel (SLGL) Ordinary Shares does Ofer Toledano directly own?

Ofer Toledano directly owns 1,461 Ordinary Shares of Sol-Gel Technologies Ltd. This reflects his current direct share ownership, separate from his stock option positions disclosed in the same Form 3 filing.

What stock options are reported for Ofer Toledano in Sol-Gel’s Form 3?

The Form 3 lists several stock options giving rights to buy Sol-Gel Ordinary Shares at exercise prices from 8.9600 to 100.0000, with expirations between 2026 and 2035, all held directly by Ofer Toledano.

Are Ofer Toledano’s Sol-Gel (SLGL) stock options vested?

Some options are already fully vested, while others vest 25% on specified dates and then in equal quarterly installments over three years, subject to Ofer Toledano’s continued service with Sol-Gel Technologies Ltd.

Does the Sol-Gel (SLGL) Form 3 show any recent insider buying or selling by Ofer Toledano?

The Form 3 functions as an initial ownership statement and lists holdings only. It does not show any explicit buy or sell transactions, focusing instead on existing Ordinary Shares and stock option positions.